Cargando…

Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 3

Detalles Bibliográficos
Autores principales:	Tseng, Yu-Hwei, Lin, Sunny Jui-Shan, Lee, Ming-Yung, Su, Yi-Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461338/ https://www.ncbi.nlm.nih.gov/pubmed/36096426 http://dx.doi.org/10.1016/j.phrs.2022.106445

Ejemplares similares

Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply
por: Lin, Sunny Jui-Shan, et al.
Publicado: (2022)

Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 2
por: Lee, Ming-Yung, et al.
Publicado: (2022)

The development and application of NRICM101 and NRICM102 for the treatment of COVID-19
por: Ho, Shung-Tai, et al.
Publicado: (2023)

A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study
por: Tsai, Keng-Chang, et al.
Publicado: (2021)

Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis
por: Wei, Wen-Chi, et al.
Publicado: (2022)

Chinese herbal prescriptions for COVID-19 management: Special reference to Taiwan Chingguan Yihau (NRICM101)
por: Su, Yi-Chang, et al.
Publicado: (2022)

Pharmacological Mechanism of NRICM101 for COVID-19 Treatments by Combined Network Pharmacology and Pharmacodynamics
por: Singh, Sher, et al.
Publicado: (2022)

NRICM101 ameliorates SARS-CoV-2–S1-induced pulmonary injury in K18-hACE2 mice model
por: Wei, Wen-Chi, et al.
Publicado: (2023)

ACE2 and a Traditional Chinese Medicine Formula NRICM101 Could Alleviate the Inflammation and Pathogenic Process of Acute Lung Injury
por: Lin, Cheng-Han, et al.
Publicado: (2023)

In Silico and In Vitro studies of taiwan chingguan yihau (NRICM101) on TNF-α/IL-1β-induced human lung cells
por: Cheng, Yih-Dih, et al.
Publicado: (2022)

Biotransformation and brain distribution of the anti-COVID-19 drug molnupiravir and herb-drug pharmacokinetic interactions between the herbal extract Scutellaria formula-NRICM101
por: Chang, Chun-Hao, et al.
Publicado: (2023)

Measurements of the beta-decay energy of $^{101}$Rb, $^{101,102}$Sr and $^{101,102}$Y
por: Balog, K, et al.
Publicado: (1990)

LPIC-1: (Exams 101 and 102)
por: Smith, Roderick W
Publicado: (2011)

Measurements on NM 102 and NM 101 with "Thorndahl" filter circuit
por: Fiebig, A
Publicado: (1980)

Author Index for Volume 102
Publicado: (2010)

The decay of cadmium isotopes of mass 100, 101 and 102 isomers in silver
por: Hnatowich, D J, et al.
Publicado: (1970)

The decay of cadmium isotopes of mass 100, 101 and 102 to isomers in silver
por: Hnatowich, D J, et al.
Publicado: (1970)

Authors’ Reply: Concerns on Generalizability
por: Chung, Hsueh-Wen, et al.
Publicado: (2023)

Author Index for Volume 101
Publicado: (2009)

The authors reply
por: Su, Hua, et al.
Publicado: (2020)

Reply to Author
por: Qiu, Lin, et al.
Publicado: (2022)

Author`s Reply
por: Gu, Jun, et al.
Publicado: (2019)

Authors' Reply
por: Tian, Di, et al.
Publicado: (2022)

Author's reply
por: Wu, Jun-Song, et al.
Publicado: (2013)

Author`s Reply
por: Yao, Mingyang, et al.
Publicado: (2019)

Allocated but not treated: the silent 16% – Authors' reply
por: Horby, Peter, et al.
Publicado: (2022)

CompTIA Linux+ Complete Study Guide (Exams LX0-101 and LX0-102)
por: Smith, Roderick W
Publicado: (2010)

LPIC-1 : Linux Professional Institute Certification study guide : exam 101-500 and exam 102-500
por: Bresnahan, Christine, et al.
Publicado: (2019)

LPIC-1 Linux Professional Institute certification study guide: exam 101-400 and exam 102-400
por: Bresnahan, Christine, et al.
Publicado: (2015)

Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
por: Bergquist, Filip, et al.
Publicado: (2022)

Treating Schizophrenia with DOTS in Developing Countries: Author's Reply
por: Farooq, Saeed
Publicado: (2007)

Authors′ reply
por: Grover, A K
Publicado: (2008)

Authors' Reply
por: Salas, Antonio, et al.
Publicado: (2006)

Author's Reply
por: Krleža-Jerić, Karmela
Publicado: (2006)

Authors' Reply
por: Bush, Eliot C, et al.
Publicado: (2006)

Author's Reply
por: Kaeberlein, Matt, et al.
Publicado: (2006)

Authors' Reply
por: Stafford, Randall S, et al.
Publicado: (2006)

Authors' Reply
por: Lacasse, Jeffrey R, et al.
Publicado: (2006)

Authors' Reply
por: Lyssenko, Valeriya, et al.
Publicado: (2006)

Author's Reply
por: Ioannidis, John P. A
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_7i75onfsar3fd9cmhja1s1ek3k